The Associations of Plasma Biomarkers of Inflammation With Histopathologic Lesions, Kidney Disease Progression, and Mortality—The Boston Kidney Biopsy Cohort Study

[1]  H. Nagaraja,et al.  Urinary Soluble CD163: a Novel Noninvasive Biomarker of Activity for Lupus Nephritis. , 2020, Journal of the American Society of Nephrology : JASN.

[2]  P. Kimmel,et al.  Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with Chronic Kidney Disease Progression in Children. , 2020, Journal of the American Society of Nephrology : JASN.

[3]  S. Weisbord,et al.  Kidney Biomarkers of Injury and Repair as Predictors of Contrast-Associated AKI: A Substudy of the PRESERVE Trial. , 2020, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[4]  D. Leaf,et al.  Soluble Urokinase Receptor and Acute Kidney Injury. , 2020, The New England journal of medicine.

[5]  A. Heinzel,et al.  Canagliflozin reduces inflammation and fibrosis biomarkers: a potential mechanism of action for beneficial effects of SGLT2 inhibitors in diabetic kidney disease , 2019, Diabetologia.

[6]  Jennifer K. Sun,et al.  A Signature of Circulating Inflammatory Proteins and Development of End Stage Renal Disease in Diabetes , 2019, Nature Medicine.

[7]  J. Kellum,et al.  Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury: A Randomized Clinical Trial , 2018, JAMA.

[8]  B. Kestenbaum,et al.  Association of Soluble TNFR-1 Concentrations with Long-Term Decline in Kidney Function: The Multi-Ethnic Study of Atherosclerosis. , 2018, Journal of the American Society of Nephrology : JASN.

[9]  J. Coresh,et al.  Soluble Urokinase-Type Plasminogen Activator Receptor in Black Americans with CKD. , 2018, Clinical journal of the American Society of Nephrology : CJASN.

[10]  Anand Srivastava,et al.  The Prognostic Value of Histopathologic Lesions in Native Kidney Biopsy Specimens: Results from the Boston Kidney Biopsy Cohort Study. , 2018, Journal of the American Society of Nephrology : JASN.

[11]  P. Libby,et al.  Inhibition of Interleukin-1β by Canakinumab and Cardiovascular Outcomes in Patients With Chronic Kidney Disease. , 2018, Journal of the American College of Cardiology.

[12]  M. Kretzler,et al.  OP-NDTJ180031 1942..2019 , 2018 .

[13]  L. Cantley,et al.  Breast Regression Protein-39/Chitinase 3-Like 1 Promotes Renal Fibrosis after Kidney Injury via Activation of Myofibroblasts. , 2017, Journal of the American Society of Nephrology : JASN.

[14]  A. Galecki,et al.  Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease. , 2017, Kidney international.

[15]  L. Fried,et al.  Plasma Biomarkers and Kidney Function Decline in Early and Established Diabetic Kidney Disease. , 2017, Journal of the American Society of Nephrology : JASN.

[16]  M. Burnier,et al.  Safety and Tolerability Study of an Intravenously Administered Small Interfering Ribonucleic Acid (siRNA) Post On-Pump Cardiothoracic Surgery in Patients at Risk of Acute Kidney Injury , 2017, Kidney international reports.

[17]  Y. Çiçek,et al.  The relationship between serum YKL-40 levels and arterial stiffness in patients with ankylosing spondylitis. , 2017, Acta reumatologica portuguesa.

[18]  A. Didangelos,et al.  Extracellular matrix proteomics identifies molecular signature of symptomatic carotid plaques , 2017, The Journal of clinical investigation.

[19]  A. Levey,et al.  Urine Fibrosis Markers and Risk of Allograft Failure in Kidney Transplant Recipients: A Case-Cohort Ancillary Study of the FAVORIT Trial. , 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  J. Himmelfarb,et al.  The CKD Classification System in the Precision Medicine Era. , 2017, Clinical journal of the American Society of Nephrology : CJASN.

[21]  Sudhir V. Shah,et al.  Association of Urinary Biomarkers of Inflammation, Injury, and Fibrosis with Renal Function Decline: The ACCORD Trial. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[22]  F. Kronenberg,et al.  Multinational Assessment of Accuracy of Equations for Predicting Risk of Kidney Failure: A Meta-analysis. , 2016, JAMA.

[23]  A. Quyyumi,et al.  Soluble Urokinase Receptor and Chronic Kidney Disease. , 2015, The New England journal of medicine.

[24]  Eric A. Miller,et al.  Linkage of NCHS Population Health Surveys to Administrative Records From Social Security Administration and Centers for Medicare Medicaid Services. , 2015, Vital and health statistics. Ser. 1, Programs and collection procedures.

[25]  W. Knowler,et al.  Tumor necrosis factor receptors 1 and 2 are associated with early glomerular lesions in type 2 diabetes , 2015, Kidney international.

[26]  Y. Kim,et al.  Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study , 2015, PloS one.

[27]  Yusuke Suzuki,et al.  Circulating TNF Receptors 1 and 2 Are Associated with the Severity of Renal Interstitial Fibrosis in IgA Nephropathy , 2015, PloS one.

[28]  T. Mayadas,et al.  TNF receptors: signaling pathways and contribution to renal dysfunction. , 2015, Kidney international.

[29]  W. Knowler,et al.  Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes , 2014, Kidney international.

[30]  Y. Kim,et al.  Circulating TNF Receptors Are Significant Prognostic Biomarkers for Idiopathic Membranous Nephropathy , 2014, PloS one.

[31]  L. Cantley,et al.  Chitinase-like protein Brp-39/YKL-40 modulates the renal response to ischemic injury and predicts delayed allograft function. , 2013, Journal of the American Society of Nephrology : JASN.

[32]  T. Mayadas,et al.  Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. , 2012, Journal of the American Society of Nephrology : JASN.

[33]  E. Salido,et al.  Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis , 2011, Nature Medicine.

[34]  H. J. Kim,et al.  Contribution of impaired Nrf2-Keap1 pathway to oxidative stress and inflammation in chronic renal failure. , 2010, American journal of physiology. Renal physiology.

[35]  Zhigang Zhang,et al.  Interval censoring , 2010, Statistical methods in medical research.

[36]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[37]  P. Harris,et al.  Research electronic data capture (REDCap) - A metadata-driven methodology and workflow process for providing translational research informatics support , 2009, J. Biomed. Informatics.

[38]  L. Tarnow,et al.  YKL-40, a Marker of Inflammation and Endothelial Dysfunction, Is Elevated in Patients With Type 1 Diabetes and Increases With Levels of Albuminuria , 2009, Diabetes Care.

[39]  M. Pencina,et al.  Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.

[40]  Y. Li,et al.  Role of ADAM17 in the ectodomain shedding of TNF‐α and its receptors by neutrophils and macrophages , 2007, Journal of leukocyte biology.

[41]  D. Adu,et al.  The relationship between albuminuria, MCP-1/CCL2, and interstitial macrophages in chronic kidney disease. , 2006, Kidney International.

[42]  G. Remuzzi,et al.  Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes. , 2006, The Journal of clinical investigation.

[43]  S. Meng,et al.  Oxidative Stress and Antioxidant Treatment in Hypertension and the Associated Renal Damage , 2005, American Journal of Nephrology.

[44]  M. Pencina,et al.  Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation , 2004, Statistics in medicine.

[45]  Jianguo Sun,et al.  Generalized log‐rank test for mixed interval‐censored failure time data , 2004, Statistics in medicine.

[46]  P. Pattynama,et al.  Complication rate and diagnostic yield of 515 consecutive ultrasound-guided biopsies of renal allografts and native kidneys using a 14-gauge Biopty gun , 2003, European Radiology.

[47]  D. Goeddel,et al.  TNF-R1 Signaling: A Beautiful Pathway , 2002, Science.

[48]  A. Schmaier,et al.  Expression and colocalization of cytokeratin 1 and urokinase plasminogen activator receptor on endothelial cells. , 2001, Blood.

[49]  C. Alpers,et al.  J Am Soc Nephrol 11: 2231–2242, 2000 Expression of the Chemokine Monocyte Chemoattractant Protein-1 and Its Receptor Chemokine Receptor 2 in Human , 2022 .

[50]  Robert Gray,et al.  A Proportional Hazards Model for the Subdistribution of a Competing Risk , 1999 .

[51]  Jon A. Wellner,et al.  A Hybrid Algorithm for Computation of the Nonparametric Maximum Likelihood Estimator from Censored Data , 1997 .

[52]  J Sun,et al.  A non-parametric test for interval-censored failure time data with application to AIDS studies. , 1996, Statistics in medicine.

[53]  L. Gesualdo,et al.  Monocyte chemotactic peptide-1 expression in acute and chronic human nephritides: a pathogenetic role in interstitial monocytes recruitment. , 1996, Journal of the American Society of Nephrology : JASN.

[54]  B. Haller,et al.  Mortality prediction in stable hemodialysis patients is refined by YKL-40, a 40-kDa glycoprotein associated with inflammation. , 2018, Kidney international.

[55]  J. Navarro-González,et al.  Effect of pentoxifylline on renal function and urinary albumin excretion in patients with diabetic kidney disease: the PREDIAN trial. , 2015, Journal of the American Society of Nephrology : JASN.

[56]  R. Atkins,et al.  Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice. , 2006, Kidney international.